PL2443105T3 - Nowe pochodne fenyloimidazolu jako inhibitor enzymu PDE10A - Google Patents

Nowe pochodne fenyloimidazolu jako inhibitor enzymu PDE10A

Info

Publication number
PL2443105T3
PL2443105T3 PL10725373T PL10725373T PL2443105T3 PL 2443105 T3 PL2443105 T3 PL 2443105T3 PL 10725373 T PL10725373 T PL 10725373T PL 10725373 T PL10725373 T PL 10725373T PL 2443105 T3 PL2443105 T3 PL 2443105T3
Authority
PL
Poland
Prior art keywords
enzyme inhibitor
pde10a enzyme
phenylimidazole derivative
novel phenylimidazole
novel
Prior art date
Application number
PL10725373T
Other languages
English (en)
Inventor
Andreas Ritzen
Jan Kehler
Morten Langgård
Jacob Nielsen
John Paul Kilburn
Mohamed M Farah
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/DK2009/050134 external-priority patent/WO2009152825A1/en
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of PL2443105T3 publication Critical patent/PL2443105T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL10725373T 2009-06-19 2010-06-17 Nowe pochodne fenyloimidazolu jako inhibitor enzymu PDE10A PL2443105T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/DK2009/050134 WO2009152825A1 (en) 2008-06-20 2009-06-19 Novel phenylimidazole derivatives as pde10a enzyme inhibitors
EP10725373.4A EP2443105B1 (en) 2009-06-19 2010-06-17 Novel phenylimidazole derivative as pde10a enzyme inhibitor
PCT/DK2010/050147 WO2010145668A1 (en) 2009-06-19 2010-06-17 Novel phenylimidazole derivative as pde10a enzyme inhibitor

Publications (1)

Publication Number Publication Date
PL2443105T3 true PL2443105T3 (pl) 2015-03-31

Family

ID=42321053

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10725373T PL2443105T3 (pl) 2009-06-19 2010-06-17 Nowe pochodne fenyloimidazolu jako inhibitor enzymu PDE10A

Country Status (27)

Country Link
EP (1) EP2443105B1 (pl)
JP (1) JP5768044B2 (pl)
AR (1) AR077144A1 (pl)
AU (1) AU2010262190B2 (pl)
CA (1) CA2765750A1 (pl)
CR (1) CR20110654A (pl)
CY (1) CY1115971T1 (pl)
DK (1) DK2443105T3 (pl)
DO (1) DOP2011000397A (pl)
ES (1) ES2527216T3 (pl)
GE (1) GEP20146100B (pl)
GT (1) GT201100322A (pl)
HR (1) HRP20141222T1 (pl)
IL (1) IL216684A (pl)
MA (1) MA33367B1 (pl)
MX (1) MX2011013400A (pl)
MY (1) MY156785A (pl)
NZ (1) NZ597203A (pl)
PL (1) PL2443105T3 (pl)
PT (1) PT2443105E (pl)
SG (1) SG176680A1 (pl)
SI (1) SI2443105T1 (pl)
SM (1) SMT201500003B (pl)
TW (1) TW201100430A (pl)
UA (2) UA102693C2 (pl)
WO (1) WO2010145668A1 (pl)
ZA (1) ZA201109271B (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8133897B2 (en) 2008-06-20 2012-03-13 H. Lundbeck A/S Phenylimidazole derivatives as PDE10A enzyme inhibitors
TWI501965B (zh) 2008-06-20 2015-10-01 Lundbeck & Co As H 作為pde10a酵素抑制劑之新穎苯基咪唑衍生物
TWI485151B (zh) 2009-12-17 2015-05-21 Lundbeck & Co As H 作為pde10a酵素抑制劑之雜芳香族苯基咪唑衍生物
US8552045B2 (en) 2010-11-19 2013-10-08 H. Lundbeck A/S Tricyclic imidazole compounds as PDE10 inhibitors
JO3089B1 (ar) * 2010-11-19 2017-03-15 H Lundbeck As مشتقات ايميدازول كمثبطات لانزيمات pde10a
AU2012219316A1 (en) 2011-02-18 2013-10-03 Allergan, Inc. Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE10A)
WO2013034755A1 (en) * 2011-09-09 2013-03-14 H. Lundbeck A/S Triazolopyrazine derivatives and their use for treating neurological and psychiatric disorders
CN103874701A (zh) * 2011-09-09 2014-06-18 H.隆德贝克有限公司 吡啶化合物和其用途
WO2013034758A1 (en) * 2011-09-09 2013-03-14 H. Lundbeck A/S Substituted triazolopyrazines and uses thereof
WO2013034761A1 (en) * 2011-09-09 2013-03-14 H. Lundbeck A/S Pyridine compounds and uses thereof
AR089361A1 (es) 2011-12-21 2014-08-20 Lundbeck & Co As H Derivados de quinolina como inhibidores de la enzima pde10a
WO2013107856A1 (en) * 2012-01-20 2013-07-25 H. Lundbeck A/S Imidazole derivatives as pde10a enzyme inhibitors
WO2013127817A1 (en) 2012-02-27 2013-09-06 H. Lundbeck A/S Imidazole derivatives as pde10a enzyme inhibitors
WO2014071044A1 (en) 2012-11-01 2014-05-08 Allergan, Inc. Substituted 6,7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde10a)
US9200016B2 (en) 2013-12-05 2015-12-01 Allergan, Inc. Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)
BR112020013697A2 (pt) * 2018-11-06 2020-12-01 H. Lundbeck A/S compostos para tratamento de sintomas negativos e comprometimentos cognitivos
WO2020094590A1 (en) * 2018-11-06 2020-05-14 H. Lundbeck A/S 5,8-dimethyl-2-[2-(1-methyl-4-phenyl-1h-imidazol-2-yl)-ethyl]-[1,2,4]triazolo[1,5-a]pyrazine hemiadipate

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826833A (en) 1984-01-30 1989-05-02 Pfizer Inc. 6-(Substituted)methylene-penicillanic and 6-(substituted)hydroxymethylpenicillanic acids and derivatives thereof
US20030032579A1 (en) 2001-04-20 2003-02-13 Pfizer Inc. Therapeutic use of selective PDE10 inhibitors
IL149106A0 (en) 2001-04-20 2002-11-10 Pfizer Prod Inc Therapeutic use of selective pde10 inhibitors
FR2824065A1 (fr) 2001-04-26 2002-10-31 Neuro3D Composes inhibiteurs des phosphodiesterases des nucleotides cycliques, preparation et utilisations
AU2003262023A1 (en) 2002-09-10 2004-04-30 Takeda Pharmaceutical Company Limited Five-membered heterocyclic compounds
DE60324449D1 (de) 2002-10-30 2008-12-11 Via Pharmaceuticals Inc Inhibitoren der phosphodiesterase der zyklischen n, und deren verwendung in therapie
ES2331519T3 (es) 2003-06-30 2010-01-07 Nycomed Gmbh Derivados de pirrolo-dihidroisoquinolina como inhibidores de pde10.
UA86591C2 (ru) 2003-06-30 2009-05-12 Алтана Фарма Аг Пирролодигидроизохинолины как ингибиторы pde10, фармацевтическая композиция на их основе
EP1651251A4 (en) 2003-07-31 2008-06-18 Bayer Pharmaceuticals Corp METHOD FOR THE TREATMENT OF DIABETES AND RELATED DISEASES USING PDE 10A INHIBITORS
BRPI0507839A (pt) * 2004-02-18 2007-05-08 Pfizer Prod Inc derivados tetraidroisoquinolinil de quinazolina e isoquinolina
FR2870539B1 (fr) 2004-05-19 2006-08-04 Greenpharma Sa Sa Nouvelles methodes et medicaments
WO2005120514A1 (en) 2004-06-07 2005-12-22 Pfizer Products Inc. Phosphodiesterase 10 inhibition as treatment for obesity-related and metabolic syndrome-related conditions
US20060019975A1 (en) 2004-07-23 2006-01-26 Pfizer Inc Novel piperidyl derivatives of quinazoline and isoquinoline
US20060160814A1 (en) 2004-09-03 2006-07-20 Arrington Mark P Phosphodiesterase 10 inhibitors
US20060183763A1 (en) * 2004-12-31 2006-08-17 Pfizer Inc Novel pyrrolidyl derivatives of heteroaromatic compounds
AU2007217750A1 (en) * 2006-02-21 2007-08-30 Amgen Inc. Cinnoline derivatives as phosphodiesterase 10 inhibitors
TWI501965B (zh) 2008-06-20 2015-10-01 Lundbeck & Co As H 作為pde10a酵素抑制劑之新穎苯基咪唑衍生物

Also Published As

Publication number Publication date
PT2443105E (pt) 2015-01-14
UA102693C2 (ru) 2013-08-12
UA106378C2 (ru) 2014-08-26
NZ597203A (en) 2013-03-28
MY156785A (en) 2016-03-31
TW201100430A (en) 2011-01-01
MX2011013400A (es) 2012-02-21
SMT201500003B (it) 2015-03-05
AR077144A1 (es) 2011-08-03
DOP2011000397A (es) 2012-07-15
CR20110654A (es) 2012-03-09
AU2010262190B2 (en) 2013-01-31
IL216684A (en) 2016-03-31
GEP20146100B (en) 2014-05-27
ZA201109271B (en) 2013-02-27
GT201100322A (es) 2014-02-06
SG176680A1 (en) 2012-01-30
WO2010145668A1 (en) 2010-12-23
HRP20141222T1 (hr) 2015-02-27
IL216684A0 (en) 2012-02-29
EP2443105A1 (en) 2012-04-25
EP2443105B1 (en) 2014-10-29
JP5768044B2 (ja) 2015-08-26
ES2527216T3 (es) 2015-01-21
CY1115971T1 (el) 2017-01-25
SI2443105T1 (sl) 2015-02-27
CA2765750A1 (en) 2010-12-23
MA33367B1 (fr) 2012-06-01
AU2010262190A1 (en) 2012-01-19
JP2012530086A (ja) 2012-11-29
DK2443105T3 (en) 2015-01-12

Similar Documents

Publication Publication Date Title
ZA201109271B (en) Novel phenylimidazole derivative as pde10a enzyme inhibitor
HK1159632A1 (en) Novel phenylimidazole derivatives as pde10a enzyme inhibitors pde10a
IL238764A0 (en) Pyrimidinones as p13k inhibitors
HK1177739A1 (en) 2-arylimidazole derivatives as pde10a enzyme inhibitors pde10a 2-
HK1177208A1 (en) Heteroaromatic phenylimidazole derivatives as pde10a enzyme inhibitors pde10a
GB201004179D0 (en) Enzyme inhibitors
GB201004178D0 (en) Enzyme inhibitors
ZA201100898B (en) Novel inhibitors
AP3342A (en) Imidazole derivatives as PDE10A enzyme inhibitors
GB0817429D0 (en) Enzyme inhibitors
HK1171446A1 (en) Phenylimidazole derivative as pde10a enzyme inhibitor pde10a
HK1189593A1 (en) Imidazole derivatives as pde10a enzyme inhibitors pde10a
GB0901616D0 (en) Enzyme inhibitors
GB0908068D0 (en) Enzyme inhibitors
GB0911102D0 (en) Enzyme inhibitor
GB0904936D0 (en) Enzyme inhibitor
GB0812443D0 (en) Enzyme inhibitors
GB0807056D0 (en) Enzyme inhibitors
GB0915927D0 (en) Novel inhibitors
GB0816125D0 (en) Novel inhibitors